US 8043623
Immunogenic peptides for the treatment of prostate and breast cancer
granted A61KA61K2039/53A61K2039/57
Quick answer
US patent 8043623 (Immunogenic peptides for the treatment of prostate and breast cancer) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/53, A61K2039/57, A61K2239/49, A61K2239/58